CORE--Monoclonal Antibody Facility
CORE--Monoclonal Antibody Facility
批准号:
6345911
负责人:
Thomas M Moran
金额:
$16.67万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2001-08-31
中文摘要
杂交瘤核心设施提供细胞培养设施,以协助研究者完成项目。 我们可以生产单克隆抗体,在某些情况下也可以生产多克隆抗体。 这包括小鼠的免疫,进行测试出血以确定免疫的程度,去除脾脏和淋巴结用于融合和实际融合。 在HAT培养基中选择杂交瘤,并在许多测定中测试特异性。 我们使用放射免疫分析法、ELISA法和蛋白质印迹法进行筛选。 通过有限稀释将产生适当特异性抗体的杂交瘤克隆两次。 为了生产大量的抗体,我们在组织培养中培养杂交瘤,或者将它们注射到姥鲛烷致敏的小鼠体内。 通过蛋白A或蛋白G层析、DEAE离子交换或在具有共价连接的抗免疫球蛋白的分离柱上从这些溶液中纯化抗体。 所有这些程序都提供给程序项目的成员。除了生产单克隆抗体外,我们还制备了广泛使用的试剂,如HA标签抗体、C-Myc标签抗体、小鼠同种型抗体、蛋白体抗体以及与同种型和同种异型匹配的任何其他对照抗体。我们还试图开发已知参与区分Th 1和Th 2免疫的受体的抗体。 目前普遍的科学观点认为,自身免疫性疾病源于Th 1免疫应答的过度激活。 我们正试图制备针对IL-12 B2受体和干扰素γ β受体的小鼠单克隆抗体,IL-12 B2受体被认为在Th 1细胞的扩增中起重要作用,干扰素γ β受体被认为参与Th 2细胞的产生。 我们已经生产并测试了针对来自已知序列的肽产生的单克隆抗IL-12 B2。 这不能结合Th 1细胞,如通过许多测定所确定的。 因此,我们制备了含有IL-12 B2链的胞外结构域的GST融合蛋白。 这通过RT-PCR从用LPS、IL-12和γ干扰素免疫后从小鼠收集的RNA进行。 我们成功地制备了PCRed这个片段,现在已经在细菌中表达。 我们将对杂交瘤使用抗病毒药物,以避免小鼠中可能存在的耐受性。 将通过ELISA筛选融合蛋白对杂交瘤进行检测,另一种GST融合蛋白作为阴性对照。 将在制备的主要表达Th 1细胞的脾细胞群上检测阳性杂交瘤上清液。
英文摘要
The hybridoma core facility provides a cell culture facility to assist the investigators in the completions of the projects. We are available to produce monoclonal and in some cases polyclonal antibodies for their use. This includes the immunization of mice, performing test bleeding to determine the degree of immunization, removal of spleens and lymph nodes for fusion and the actually fusion. Hybridomas are selected in HAT medium and tested in a number of assays for specificity. We screen using radioimmunoassay, ELISA, and western blotting. Hybridomas producing antibodies of the appropriate specificity are cloned two times by limiting dilution. To produce large quantities of antibodies we grow the hybridomas in tissue culture, or injected them into pristane primed mice. The antibodies are purified from these solution by Protein A or Protein G chromatography, DEAE ion exchange or on separose columns with covalently attached anti- immunoglobulins. All of these procedures are available to the members of the program project. In addition to production of monoclonal we prepare widely used reagents such as antibodies to HA tag, C-Myc tag, antibodies to mouse isotypes, antibodies to the proteosomes, and any other control antibodies matched for isotype and allotype. We are also trying to develop antibodies to receptor known to be involved in the discriminating Th1 and Th2 immunity. Common scientific thinking at this time suggests that autoimmune disease stems from overactivation of Th1 immune response. We are trying to prepare mouse monoclonals against the IL-12B2 receptor, believed to play an important role in expansion of Th1 cells and the interferon Gamma Beta receptor believed to be involved in generation of Th2 cells. We have produced and tested monoclonal anti-IL-12B2 produced against a peptide derived from the known sequence. This failed to bind to Th1 cells as determined by a number of assays. Therefore, we prepared a GST fusion protein containing the extracellular domain of the IL-12B2 chain. This was done by RT-PCR from RNA collected from mice following immunization with LPS, IL-12 and gamma interferon. We successful prepared PCRed this fragment and have now expressed it in bacteria. We will use Hamster for the hybridoma in order to avoid the tolerance which might be present in the mouse. The hybridomas will be tested by ELISA screening on the fusion protein with another GST fusion as a negative control. Positive hybridoma supernatnats will be tested on spleen cell populations prepared to express primarily Th1 cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Investigating Viral Immunity and Antagonism
-
批准号:7924262
-
项目类别:
-
资助金额:$140.0万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Response in Influenza Virus Infection
-
批准号:7905026
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Response in Influenza Virus Infection
-
批准号:7679763
-
项目类别:
-
资助金额:$75.47万
-
财政年份:2009
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Dendritic Cells in Influenza Virus Infection
-
批准号:7498938
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2007
-
负责人:Thomas M Moran
-
依托单位:
Inflammatory Dendritic Cells in Influenza Virus Infection
-
批准号:7391491
-
项目类别:
-
资助金额:$24.86万
-
财政年份:2007
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:6948195
-
项目类别:
-
资助金额:$404.21万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Technological Development Component
-
批准号:6849599
-
项目类别:
-
资助金额:$163.32万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7285664
-
项目类别:
-
资助金额:$396.08万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7492932
-
项目类别:
-
资助金额:$395.9万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:7112409
-
项目类别:
-
资助金额:$401.2万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Core--Educational Component
-
批准号:6849607
-
项目类别:
-
资助金额:$15.98万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
Center for Investigating Viral Immunity and Antagonism
-
批准号:6845471
-
项目类别:
-
资助金额:$397.19万
-
财政年份:2004
-
负责人:Thomas M Moran
-
依托单位:
R21 Planning Grant for the CCTRHIB Program
-
批准号:6700423
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2003
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6610319
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2002
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6480395
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2001
-
负责人:Thomas M Moran
-
依托单位:
VIRUS INDUCED DC MATURATION AND CELLULAR IMMUNITY
-
批准号:6331753
-
项目类别:
-
资助金额:$14.98万
-
财政年份:2000
-
负责人:Thomas M Moran
-
依托单位:
CORE--Monoclonal Antibody Facility
-
批准号:6201086
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1999
-
负责人:Thomas M Moran
-
依托单位:
Th1 and Th2 Responses in Viral Immunity
-
批准号:7385910
-
项目类别:
-
资助金额:$31.53万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
Th1 and Th2 Responses in Viral Immunity
-
批准号:7039106
-
项目类别:
-
资助金额:$33.1万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
TH1 and TH2 Responses in Viral Immunity
-
批准号:7664222
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1998
-
负责人:Thomas M Moran
-
依托单位:
海外基金